SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001016169-10-000004
Filing Date
2010-04-09
Accepted
2010-04-09 16:52:11
Documents
3
Period of Report
2010-05-27
Effectiveness Date
2010-04-09

Document Format Files

Seq Description Document Type Size
1 proxy.htm DEF 14A 1032453
2 paulw.jpg GRAPHIC 3010
3 bob.jpg GRAPHIC 2075
  Complete submission text file 0001016169-10-000004.txt   1041440
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 10743076
SIC: 3841 Surgical & Medical Instruments & Apparatus